Pontifax Management 4 G.P. (2015) Ltd.

Insider Reports History

Entity
Company
Location
14 Shenkar Street, Beit Ofek, Herzliya Pituach, Israel
Signature
/s/ Keith Regnante, Attorney-in-Fact for Pontifax Management 4 G.P. (2015) Ltd.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pontifax Management 4 G.P. (2015) Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. 10%+ Owner Common Stock 1.23M $55.5M $45.29 Nov 29, 2022 Indirect
Eloxx Pharmaceuticals, Inc. 10%+ Owner Common Stock 617K $444K $0.72 May 13, 2021 By Pontifax Investment Fund
Keros Therapeutics, Inc. 10%+ Owner Call Options (obligation to sell) 0 Nov 29, 2022 Indirect

Insider Reports Filed by Pontifax Management 4 G.P. (2015) Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. Nov 29, 2022 6 -$1 4 Nov 30, 2022 10%+ Owner
ELOX Eloxx Pharmaceuticals, Inc. May 13, 2021 4 $8M 4 May 17, 2021 10%+ Owner
KROS Keros Therapeutics, Inc. Apr 7, 2020 0 $0 3/A Nov 30, 2022 10%+ Owner